Clinical outcomes of subcutaneous implantable cardiac defibrillator implantation - Iran SICD registry.
Autor: | Mehdinejadshani M; Department of Cardiac Electrophysiology, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran., Fallah H; Department of Cardiology, Faculty of Medicine, Ayatollah Mousavi Hospital, Zanjan University of Medical Sciences, Zanjan, Iran., Kamali F; Department of Cardiac Electrophysiology, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.; Cardiac Electrophysiology Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran., Alizadeh-Diz A; Department of Cardiac Electrophysiology, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.; Cardiac Electrophysiology Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran., Eslami M; Department of Cardiology, School of Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran., Golabchi A; The Advocate Center for Clinical Research, Ayatollah Yasrebi Hospital, Kashan, Iran., Taherpour M; Cardiology Department, Razavi Hospital, Mashhad, Iran., Shahabi J; Heart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran., Mollazadeh R; Department of Cardiology, School of Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran., Madadi S; Department of Cardiac Electrophysiology, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.; Cardiac Electrophysiology Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran., Azhari A; Heart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran., Sodagar A; Electrophysiology Department, NIOC Hospital, Tehran, Iran., Eftekharzadeh M; Tehran Arrhythmia Clinic, Tehran, Iran., Oraii S; Tehran Arrhythmia Clinic, Tehran, Iran., Fazelifar A; Department of Cardiac Electrophysiology, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.; Cardiac Electrophysiology Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran., Kazemisaeed A; Cardiology Department, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran., Ghorbanisharif A; Tehran Arrhythmia Clinic, Tehran, Iran., Dalili M; Department of Cardiac Electrophysiology, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.; Cardiac Electrophysiology Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran., Khorgami M; Department of Cardiac Electrophysiology, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.; Cardiac Electrophysiology Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran., Heidari-Bakavoli A; Department of Cardiovascular Disease, Faculty of Medcine, Mashhad University of Medical Sciences, Mashahd, Iran., Jorat M; Cardiology Department, Shiraz University of Medical Sciences, Shiraz, Iran., Nikoo H; Non-Communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., Kheirkhah J; Department of Cardiology, School of Medicine, Heshmat Hospital, Guilan University of Medical Sciences, Rasht, Iran., Saravi M; Department of Cardiology, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran., Khodaparast M; Zavareh Atherosclerosis Research Center, Baqyitallah University of Medical Sciences, Tehran, Iran., Mirzaali M; Shafa Hospital, Golestan University of Medical Sciences, Gorgan, Iran., Emkanjoo Z; Department of Cardiac Electrophysiology, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.; Cardiac Electrophysiology Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran., Mirmasoumi M; Tehran Arrhythmia Clinic, Tehran, Iran., Sadeghian S; Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran., Mokhtari M; Cardiac Electrophysiology Department, Shahid Chamran Cardiovascular Medical and Research Center, Isfahan University of Medical Science, Isfahan, Iran., Hedayati-Goudarzi M; Cardiology Department, Rohani Hospital, School of Medicine, Babol University of Medical Sciences, Babol, Iran., Haghjoo M; Department of Cardiac Electrophysiology, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.; Cardiac Electrophysiology Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran. |
---|---|
Jazyk: | angličtina |
Zdroj: | Pacing and clinical electrophysiology : PACE [Pacing Clin Electrophysiol] 2023 Apr; Vol. 46 (4), pp. 273-278. Date of Electronic Publication: 2023 Mar 02. |
DOI: | 10.1111/pace.14668 |
Abstrakt: | Background: The subcutaneous implantable-defibrillator (S-ICD) is a relatively new alternative to the transvenous ICD system to minimize intravascular lead-related complications. This paper presents outcome of SICD implantation in patients enrolled in Iran S-ICD registry. Methods: Between October 2015 and June 2022, this prospective multicenter national registry included 223 patients with a standard indication for an ICD, who neither required bradycardia pacing nor needed cardiac resynchronization to evaluate the early post-implant complications and long-term follow-up results of the S-ICD system. Results: The mean age of the patients was 45 ± 17 years. The majority (79.4%) were male. Ischemic cardiomyopathy (39.5%) was the most common underlying disorder among patients selected for S-ICD implant. Most study patients (68.6%) had ICD for primary prevention of sudden cardiac death. Seven patients (3.1%) were found to have suboptimal lead positions. Six patients (2.7%) developed a pocket hematoma; all were managed medically. During a mean follow-up of 2 years, the appropriate therapy was recorded in 13% of the patients and inappropriate ICD intervention mainly due to supraventricular tachycardia in 8.9%. Pocket infection was observed in four patients (1.8%) and five patients (2.2%) died mainly due to heart failure. Conclusion: S-ICDs were effective at detecting and treating both induced and spontaneous ventricular arrhythmias. Major clinical complications were rare. (© 2023 Wiley Periodicals LLC.) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |